Market Cap 11.53B
Revenue (ttm) 2.76B
Net Income (ttm) 270.39M
EPS (ttm) N/A
PE Ratio 20.04
Forward PE 20.53
Profit Margin 9.81%
Debt to Equity Ratio 0.41
Volume 1,331,000
Avg Vol 1,285,538
Day's Range N/A - N/A
Shares Out 117.87M
Stochastic %K 59%
Beta 0.97
Analysts Strong Sell
Price Target $118.75

Company Profile

Revvity, Inc. provides health sciences solutions, technologies, and services worldwide. The company's Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and DNA sequencing services. Its Diagnostics segment offers instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 781 663 6900
Address:
77 4th Avenue, Waltham, United States
JarvisFlow
JarvisFlow Jun. 26 at 6:01 PM
B of A Securities has updated their rating for Revvity ( $RVTY ) to Buy with a price target of 110.
0 · Reply
Quantumup
Quantumup May. 12 at 3:53 PM
BofA Asks and Answers: on a, "Potential reset / reduction of China tariffs: Who stands to benefit the most? — Biggest beneficiaries: $TMO [Buy-$545], $AVTR , $DHR [Buy-$230], $RVTY [Buy-$116], MTD, ILMN [Underperform-$70]" ELAN BofA said in its note:
0 · Reply
Armonica423
Armonica423 May. 10 at 10:09 PM
$RVTY Big exposure for Cody at 3 oncology conferences this coming week, do your dd research
0 · Reply
Estimize
Estimize May. 6 at 10:12 AM
Wall St is expecting 1.14 EPS for $RVTY Q2 [Reporting 08/04 BMO] http://www.estimize.com/intro/rvty?chart=historical&metric_name=eps&utm_co
0 · Reply
JarvisFlow
JarvisFlow May. 1 at 1:16 PM
UBS has updated their rating for Revvity ( $RVTY ) to Buy with a price target of 115.
0 · Reply
JarvisFlow
JarvisFlow Apr. 29 at 5:21 PM
Goldman Sachs has updated their rating for Revvity ( $RVTY ) to Buy with a price target of 125.
0 · Reply
JarvisFlow
JarvisFlow Apr. 29 at 3:19 PM
JP Morgan has adjusted their stance on Revvity ( $RVTY ), setting the rating to Neutral with a target price of 120 → 100.
0 · Reply
JarvisFlow
JarvisFlow Apr. 29 at 12:30 PM
Baird has adjusted their stance on Revvity ( $RVTY ), setting the rating to Outperform with a target price of 127 → 125.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Apr. 28 at 3:03 PM
$RVTY Q1 '25 Earnings Results & Recap Revvity's Q1 adjusted EPS of $1.01 surpassed the est. $0.95, while revenue of $665 million slightly exceeded the $661 million estimate; however, organic growth was impacted by lower-than-expected academic spending, and tariffs will negatively affect margins.
0 · Reply
bhaviknair
bhaviknair Apr. 28 at 1:11 PM
$RVTY Revvity Q1 Earnings Surpass Street Estimates, Investors Cheer 2025 Revised Revenue Guidance https://stocktwits.com/news-articles/markets/equity/revvity-q1-2025-earnings/chQxxMfRbhj
0 · Reply
Latest News on RVTY
Revvity: Despite Facing Multiple Headwinds, Shares Are A Buy

May 9, 2025, 10:35 AM EDT - 7 weeks ago

Revvity: Despite Facing Multiple Headwinds, Shares Are A Buy


Revvity to Present at Upcoming Investor Conferences

Apr 30, 2025, 8:00 AM EDT - 2 months ago

Revvity to Present at Upcoming Investor Conferences


Revvity, Inc. (RVTY) Q1 2025 Earnings Call Transcript

Apr 28, 2025, 11:49 AM EDT - 2 months ago

Revvity, Inc. (RVTY) Q1 2025 Earnings Call Transcript


Revvity Board Declares Quarterly Dividend

Apr 24, 2025, 4:05 PM EDT - 2 months ago

Revvity Board Declares Quarterly Dividend


Revvity to Hold Earnings Call on Monday, April 28, 2025

Apr 3, 2025, 8:00 AM EDT - 3 months ago

Revvity to Hold Earnings Call on Monday, April 28, 2025


Revvity, Inc. (RVTY) Q4 2024 Earnings Call Transcript

Jan 31, 2025, 9:34 AM EST - 5 months ago

Revvity, Inc. (RVTY) Q4 2024 Earnings Call Transcript


Revvity Ignites Scientific Breakthroughs at SLAS2025

Jan 23, 2025, 8:00 AM EST - 5 months ago

Revvity Ignites Scientific Breakthroughs at SLAS2025


Revvity to Present at J.P. Morgan Healthcare Conference

Dec 17, 2024, 8:00 AM EST - 6 months ago

Revvity to Present at J.P. Morgan Healthcare Conference


Safe Biopharma: Revvity's Recurring Revenues And Diagnostics

Dec 16, 2024, 12:27 AM EST - 7 months ago

Safe Biopharma: Revvity's Recurring Revenues And Diagnostics


Revitty (RVTY) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 12:30 PM EST - 8 months ago

Revitty (RVTY) Q3 2024 Earnings Call Transcript


Revvity To Hold Earnings Call on Monday, November 4, 2024

Oct 7, 2024, 8:00 AM EDT - 9 months ago

Revvity To Hold Earnings Call on Monday, November 4, 2024


Diagnostic Products Demand Boosts Profit and Sales at Revvity

Jul 29, 2024, 11:25 AM EDT - 11 months ago

Diagnostic Products Demand Boosts Profit and Sales at Revvity


Revvity, Inc. (RVTY) Q2 2024 Earnings Call Transcript

Jul 29, 2024, 11:23 AM EDT - 11 months ago

Revvity, Inc. (RVTY) Q2 2024 Earnings Call Transcript


Revvity Announces Financial Results for the Second Quarter of 2024

Jul 29, 2024, 6:00 AM EDT - 11 months ago

Revvity Announces Financial Results for the Second Quarter of 2024


Revvity To Hold Earnings Call on Monday, July 29, 2024

Jul 9, 2024, 8:00 AM EDT - 1 year ago

Revvity To Hold Earnings Call on Monday, July 29, 2024


Revvity, Inc. (RVTY) Q1 2024 Earnings Call Transcript

Apr 29, 2024, 11:28 AM EDT - 1 year ago

Revvity, Inc. (RVTY) Q1 2024 Earnings Call Transcript


JarvisFlow
JarvisFlow Jun. 26 at 6:01 PM
B of A Securities has updated their rating for Revvity ( $RVTY ) to Buy with a price target of 110.
0 · Reply
Quantumup
Quantumup May. 12 at 3:53 PM
BofA Asks and Answers: on a, "Potential reset / reduction of China tariffs: Who stands to benefit the most? — Biggest beneficiaries: $TMO [Buy-$545], $AVTR , $DHR [Buy-$230], $RVTY [Buy-$116], MTD, ILMN [Underperform-$70]" ELAN BofA said in its note:
0 · Reply
Armonica423
Armonica423 May. 10 at 10:09 PM
$RVTY Big exposure for Cody at 3 oncology conferences this coming week, do your dd research
0 · Reply
Estimize
Estimize May. 6 at 10:12 AM
Wall St is expecting 1.14 EPS for $RVTY Q2 [Reporting 08/04 BMO] http://www.estimize.com/intro/rvty?chart=historical&metric_name=eps&utm_co
0 · Reply
JarvisFlow
JarvisFlow May. 1 at 1:16 PM
UBS has updated their rating for Revvity ( $RVTY ) to Buy with a price target of 115.
0 · Reply
JarvisFlow
JarvisFlow Apr. 29 at 5:21 PM
Goldman Sachs has updated their rating for Revvity ( $RVTY ) to Buy with a price target of 125.
0 · Reply
JarvisFlow
JarvisFlow Apr. 29 at 3:19 PM
JP Morgan has adjusted their stance on Revvity ( $RVTY ), setting the rating to Neutral with a target price of 120 → 100.
0 · Reply
JarvisFlow
JarvisFlow Apr. 29 at 12:30 PM
Baird has adjusted their stance on Revvity ( $RVTY ), setting the rating to Outperform with a target price of 127 → 125.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Apr. 28 at 3:03 PM
$RVTY Q1 '25 Earnings Results & Recap Revvity's Q1 adjusted EPS of $1.01 surpassed the est. $0.95, while revenue of $665 million slightly exceeded the $661 million estimate; however, organic growth was impacted by lower-than-expected academic spending, and tariffs will negatively affect margins.
0 · Reply
bhaviknair
bhaviknair Apr. 28 at 1:11 PM
$RVTY Revvity Q1 Earnings Surpass Street Estimates, Investors Cheer 2025 Revised Revenue Guidance https://stocktwits.com/news-articles/markets/equity/revvity-q1-2025-earnings/chQxxMfRbhj
0 · Reply
theflynews
theflynews Apr. 28 at 12:56 PM
Morning Movers: Earnings results and macroeconomic data in focus this week - $RVTY - https://thefly.com/permalinks/entry.php/RVTYid4114917?
0 · Reply
DonCorleone77
DonCorleone77 Apr. 28 at 10:42 AM
$RVTY Revvity backs 2025 adjusted EPS view $4.90-$5.00, consensus $4.94 Raises 2025 revenue view to $2.83B-$2.87B from $2.8B-$2.85B, consensus $2.83B.
0 · Reply
DonCorleone77
DonCorleone77 Apr. 28 at 10:41 AM
$RVTY Revvity reports Q1 adjusted EPS $1.01, consensus 95c Reports Q1 revenue $665M, consensus $661.66M. "Revvity navigated a dynamic environment and delivered strong Q1 results," said CEO Prahlad Singh. "Our strong execution combined with the uniqueness of our businesses drove our revenue, earnings and cash flow to each exceed our expectations in the quarter. Our first quarter performance positions us well for the remainder of the year as we continue to adapt to an evolving macroeconomic backdrop."
0 · Reply
DailyTrendDrifter
DailyTrendDrifter Apr. 24 at 7:23 PM
$RVTY $TICKER could be a good bet, but @Ro_Patel bro this is not your usual “maybe it’ll move” setup this is a full-blown storm forming - and it’s all lining up at the same time 💬 reddit, twitter, discord - everyone’s talking 📰 outta nowhere, major news sites started dropping promo pieces 📢 ad campaigns everywhere - stocktwits, youtube, tiktok… it’s literally in your face 📈 tradingview flipped HARD - from neutral to STRONG BUY with a $16 target (+400%) and listen... there’s word going around if Petra Stark makes any kind of statement today or tomorrow that’s it guaranteed pump early next week not “likely”, not “maybe” - guaranteed 💥 some even say there might be japanese whales or straight-up hackers behind it they’ve pulled off similar runs before - and they don’t miss 🎯 everything’s screaming early entry you’ll either be in now or crying next week while it gaps $6+ like it’s nothing no one can say you weren’t warned this is how it always starts - noise, data, hype, then boom
0 · Reply
Estimize
Estimize Apr. 24 at 1:00 PM
Wall St is expecting 0.95 EPS for $RVTY Q1 [Reporting 04/28 BMO] http://www.estimize.com/intro/rvty?chart=historical&metric_name=eps&utm_co
0 · Reply
JarvisFlow
JarvisFlow Apr. 21 at 1:01 PM
Baird has updated their rating for Revvity ( $RVTY ) to Outperform with a price target of 127.
0 · Reply
JarvisFlow
JarvisFlow Apr. 17 at 3:57 PM
Wells Fargo has adjusted their stance on Revvity ( $RVTY ), setting the rating to Equal-Weight with a target price of 130 → 102.
0 · Reply
JarvisFlow
JarvisFlow Apr. 10 at 3:12 PM
Barclays has updated their rating for Revvity ( $RVTY ) to Overweight with a price target of 110.
0 · Reply
OpenOutcrier
OpenOutcrier Apr. 2 at 8:00 PM
RECAP 4/2 +Pos Comments: $VPG + Citron $RVTY + RayJay $CME + RayJay RECAP 4/2 -Neg Comments: $GWH - TD Cowen $EWTX - Scotiabank Live Breaking trading news www.openoutcrier.com
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 24 at 1:38 PM
$RVTY Digging into Revvity's strategic pivot. Life sciences segment took a hit but diagnostics showing resilience. Immunodiagnostics and reproductive health segments looking strong. Cautiously optimistic on their 2025 guidance. Might add a small position if market gives a good entry point. good article: https://beyondspx.com/article/revvity-rvty-revolutionizing-the-life-sciences-landscape
0 · Reply
d_risk
d_risk Feb. 26 at 4:51 AM
$RVTY - Revvity Inc. Common Stock - 10K - Updated Risk Factors RVTY's 2025 10-K Risk Factors highlight new threats from deficit reduction efforts, acquisition challenges, supply chain vulnerabilities, cyber-attacks, and evolving regulations, alongside increased international exposure and stock volatility triggers. #Risk https://d-risk.ai/RVTY/10-K/2025-02-25
0 · Reply
JackDarwin
JackDarwin Feb. 20 at 1:21 PM
$RVTY Bullish Engulfing Candlestick Pattern
0 · Reply